Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-071653
Filing Date
2023-06-15
Accepted
2023-06-15 16:56:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2318846d1_defa14a.htm DEFA14A 17130
2 GRAPHIC logo.jpg GRAPHIC 3284
  Complete submission text file 0001104659-23-071653.txt   22736
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26770 | Film No.: 231018177
SIC: 2836 Biological Products, (No Diagnostic Substances)